ICON Public Limited Company (ICLR)

309.02 +7.95 (+2.64%) 收市：04:00PM EDT

ICON Public Limited Company

South County Business Park
Leopardstown
Dublin D18 X5R3
Ireland
353 1 291 2000
https://www.iconplc.com

版塊: Healthcare
行業: Diagnostics & Research
全職員工: 41,150

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. John Climax Ph.D.	Founder & Independent Non-Executive Director	90k	無	1953
Mr. Brendan Brennan	Chief Financial Officer	1.07M	無	1979
Dr. Steven A. Cutler MBA, Ph.D.	CEO & Director	2.54M	無	1960
Jonathan Andrew Curtain	Senior Vice President of Corporate & Commercial Finance	無	無	1976
Mr. Thomas N. O'Leary	Chief Information Officer	無	無	無
Mr. Diarmaid Cunningham	Chief Administrative Officer, General Counsel & Company Secretary	無	無	1975
Ms. Niamh Murphy	Director of Corporate Communications	無	無	無
Mr. David Green	Vice President of Marketing	無	無	無
Mr. Joe Cronin	Chief Human Resources Officer	無	無	無
Mr. Simon Holmes	President of Corporate Investments & Partnerships	無	無	1967

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

公司管治

截至 無 止，ICON Public Limited Company 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。